Trial Profile
Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE in the Use of SPECT Imaging for Upper Extremity Tremor
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs NAV 5001 (Primary)
- Indications Parkinson's disease
- Focus Diagnostic use
- Acronyms POET-2
- Sponsors Alseres Pharmaceuticals
- 18 May 2014 New trial record